2021
DOI: 10.1093/nar/gkab1063
|View full text |Cite
|
Sign up to set email alerts
|

The Human Disease Ontology 2022 update

Abstract: The Human Disease Ontology (DO) (www.disease-ontology.org) database, has significantly expanded the disease content and enhanced our userbase and website since the DO’s 2018 Nucleic Acids Research DATABASE issue paper. Conservatively, based on available resource statistics, terms from the DO have been annotated to over 1.5 million biomedical data elements and citations, a 10× increase in the past 5 years. The DO, funded as a NHGRI Genomic Resource, plays a key role in disease knowledge organization, representa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
80
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
4
3
3

Relationship

1
9

Authors

Journals

citations
Cited by 139 publications
(97 citation statements)
references
References 35 publications
0
80
0
1
Order By: Relevance
“…In the Alliance, the GO ontologies are used for annotation to molecular functions, biological processes, and cellular components ( https://geneontology.org ); Chemical Entities of Biological Interest (ChEBI; Hastings et al 2016 ) is used for chemical entities; Evidence & Conclusion Ontology for evidence types (ECO; Giglio et al 2019 ); Ontology of bioscientific data analysis and data management (EDAM) for metadata ( Ison et al 2013 ); Experimental Factor Ontology for experimental variables (EFO; Malone et al 2010 ); Human Phenotype Ontology for human phenotypes (HPO; Köhler et al 2021 ); Mammalian Phenotype ontology for mouse and rat phenotypes (MP; Smith and Eppig 2009 ); WBPhenotype for worm phenotypes ( Schindelman et al 2011 ); Drosophila Phenotype Ontology for fly phenotypes (DPO; Osumi-Sutherland et al 2013 ); Ascomycete Phenotype Ontology for yeast phenotypes (APO; Engel et al 2010 ); Proteomics Standards Initiative—Molecular Interaction for molecular interactions (PSI-MI; Kerrien et al 2007 ), Proteomics Standards Initiative—Protein Modification Ontology for protein modifications (PSI-MOD; Montecchi-Palazzi et al 2008 ); Disease Ontology for human disease and disease model annotations (DO; Schriml et al 2022 ); the Cell Ontology for cell type (CL; Diehl et al 2016 ); Uberon for animal anatomy ( Haendel et al 2014 ); Mouse Developmental Anatomy Ontology for mouse anatomy (EMAPA; Hayamizu et al 2015 ); Zebrafish anatomy (ZFA) and development ontology for (ZFA; Van Slyke et al 2014 ); Drosophila gross anatomy for fly anatomy (FBbt; Costa et al 2013 ); C. elegans Gross Anatomy Ontology for worm anatomy (WBbt; Lee and Sternberg 2003 ); WormBase life stage ontology for worm developmental stages (WBls; W. Chen and D. Raciti, unpublished); Sequence Ontology (SO; Mungall et al 2011 ; Sant et al 2021 ) for sequence features; Relation Ontology (RO; Smith et al 2005 ) for relations; and Measurement Method Ontology (MMO; Smith et al 2013 ) for expression assays.…”
Section: Introduction: the Model Organism Databases The Goals And The...mentioning
confidence: 99%
“…In the Alliance, the GO ontologies are used for annotation to molecular functions, biological processes, and cellular components ( https://geneontology.org ); Chemical Entities of Biological Interest (ChEBI; Hastings et al 2016 ) is used for chemical entities; Evidence & Conclusion Ontology for evidence types (ECO; Giglio et al 2019 ); Ontology of bioscientific data analysis and data management (EDAM) for metadata ( Ison et al 2013 ); Experimental Factor Ontology for experimental variables (EFO; Malone et al 2010 ); Human Phenotype Ontology for human phenotypes (HPO; Köhler et al 2021 ); Mammalian Phenotype ontology for mouse and rat phenotypes (MP; Smith and Eppig 2009 ); WBPhenotype for worm phenotypes ( Schindelman et al 2011 ); Drosophila Phenotype Ontology for fly phenotypes (DPO; Osumi-Sutherland et al 2013 ); Ascomycete Phenotype Ontology for yeast phenotypes (APO; Engel et al 2010 ); Proteomics Standards Initiative—Molecular Interaction for molecular interactions (PSI-MI; Kerrien et al 2007 ), Proteomics Standards Initiative—Protein Modification Ontology for protein modifications (PSI-MOD; Montecchi-Palazzi et al 2008 ); Disease Ontology for human disease and disease model annotations (DO; Schriml et al 2022 ); the Cell Ontology for cell type (CL; Diehl et al 2016 ); Uberon for animal anatomy ( Haendel et al 2014 ); Mouse Developmental Anatomy Ontology for mouse anatomy (EMAPA; Hayamizu et al 2015 ); Zebrafish anatomy (ZFA) and development ontology for (ZFA; Van Slyke et al 2014 ); Drosophila gross anatomy for fly anatomy (FBbt; Costa et al 2013 ); C. elegans Gross Anatomy Ontology for worm anatomy (WBbt; Lee and Sternberg 2003 ); WormBase life stage ontology for worm developmental stages (WBls; W. Chen and D. Raciti, unpublished); Sequence Ontology (SO; Mungall et al 2011 ; Sant et al 2021 ) for sequence features; Relation Ontology (RO; Smith et al 2005 ) for relations; and Measurement Method Ontology (MMO; Smith et al 2013 ) for expression assays.…”
Section: Introduction: the Model Organism Databases The Goals And The...mentioning
confidence: 99%
“…Further, the machine-readability contents of WikiPathways provides a unique high level of interoperability with all major databases for genes, proteins, chemicals and probes as well as direct links to PubMed entries, PubMedCentral, and Scholia ( 59 ), and is annotated with the Pathway Ontology ( 60 ), Human Disease Ontology ( 61 ) and Cell Type Ontology ( 62 ) for improved semantic meaning and usefulness in computational approaches. These aspects make the pathway compliant to most types of data for analysis purposes, allow for a variety of computational approaches, workflows, and integrations with other tools and databases ( 20 , 21 ), and align with the recently established FAIR (Findable, Accessible, Interoperable and Reusable) guiding principles for scientific data management and stewardship ( 63 ), which dictate the future of data-driven science.…”
Section: Discussionmentioning
confidence: 99%
“…Medical Subject Headings (MeSH) is the standard used for cancer and drugs, while HUGO Gene Nomenclature Committee is for genes. We also map diseases to Disease Ontology (37) terms whenever possible to make them more interoperable with databases like CIViC (8). We adopted the standardized findings of tmVar without additional processing due to the vast number of variations and the lack of a single standard library akin to the MeSH entry library.…”
Section: System Descriptionmentioning
confidence: 99%